Application 213005
- Type
- NDA
- Sponsor
- Liquidia Technologies, Inc.
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | YUTREPIA | TREPROSTINIL SODIUM | POWDER;INHALATION | EQ 0.0265MG BASE/INH | Yes | Yes |
| 002 | YUTREPIA | TREPROSTINIL SODIUM | POWDER;INHALATION | EQ 0.053MG BASE/INH | Yes | Yes |
| 003 | YUTREPIA | TREPROSTINIL SODIUM | POWDER;INHALATION | EQ 0.0795MG BASE/INH | Yes | Yes |
| 004 | YUTREPIA | TREPROSTINIL SODIUM | POWDER;INHALATION | EQ 0.106MG BASE/INH | Yes | Yes |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 82398 | ORIG | 2025-06-02 |
| 69267 | ORIG | 2021-11-05 |